CION Cancer Clinics
The BARD1 gene: what it does and why it matters | CION Cancer Clinics
BARD1 is a gene that helps your cells repair broken DNA, working as the partner of BRCA1. A fault in BARD1 raises breast cancer risk, though less steeply than a BRCA1 fault. This page explains what the gene does, how a fault leads to risk, and why most carriers are offered closer screening rather than surgery. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
On this page
- What does the BARD1 gene actually do?
- What job does BARD1 do in a healthy cell?
- How does a BARD1 fault raise cancer risk?
- What do the words on a BARD1 report mean?
- How is BARD1 different from BRCA1?
- What do families get wrong about BARD1?
- What this page cannot tell you
- Common questions about the BARD1 gene
The short answer
What does the BARD1 gene actually do?
BARD1 is a gene that helps your cells repair broken DNA. It works as the close partner of BRCA1, and the two proteins do their repair job together. When BARD1 is faulty, that repair team works less well, and the risk of breast cancer rises above that of other women.
A partner gene, not a famous one
Most families have heard of BRCA1 and BRCA2. Far fewer have heard of BARD1, because it was only added to routine test panels in recent years. It usually turns up on a report because a panel of many genes was tested at once, not because anyone was looking for it.
Why the gene matters to you
A BARD1 fault is considered a moderate-risk finding. It raises breast cancer risk, but not as steeply as a BRCA1 fault. That difference shapes what doctors suggest next, which is usually closer breast screening rather than surgery. It also means relatives can be tested for the exact same fault.
A BARD1 fault is not a cancer diagnosis. It is a statement about risk.Inside the cell
What job does BARD1 do in a healthy cell?
BARD1 has one main role and a few side roles. All of them come back to keeping DNA intact.
It holds BRCA1 steady
BARD1 and BRCA1 lock together into a pair. Without BARD1, the BRCA1 protein is unstable and breaks down quickly. The pair is what actually does the work.
It helps fix double breaks
The most dangerous DNA damage is a break across both strands. The BRCA1 and BARD1 pair helps the cell repair these breaks accurately, using the matching copy of DNA as a template.
When repair fails
- Mistakes pile up in the cell
- Some mistakes switch off growth brakes
- A cell can start growing unchecked
It works as a tumour suppressor
Genes like BARD1 are called tumour suppressors. Their normal job is to stop damaged cells from turning into cancer. A fault weakens that brake.
What it does not do
BARD1 does not decide your risk on its own. Family history, other genes, age and hormones all play a part. It is one piece of a larger picture.
Not sure whether this applies to you?
Ask an oncologistFrom fault to risk
How does a BARD1 fault raise cancer risk?
-
You are born with two copies
One copy of BARD1 comes from your mother and one from your father. One working copy is usually enough to keep repair going.
-
An inherited fault removes one copy
A carrier is born with only one working copy in every cell. Nothing is wrong at birth. The cells still repair DNA normally.
-
The second copy can be damaged in one cell
Over a lifetime, ordinary copying errors can damage the remaining copy in a single breast cell. That cell now has no working BARD1.
-
Repair breaks down in that cell
Without the BRCA1 and BARD1 pair, broken DNA is patched badly. Errors build up and, occasionally, a tumour forms.
-
Which is why risk is not certainty
The second step is partly chance. Many carriers never develop cancer at all, and watching closely helps catch the ones who do early.
On your report
What do the words on a BARD1 report mean?
- Germline
- Present in every cell from birth, and so it can be passed on. This is what a BARD1 result on a blood test refers to.
- Pathogenic variant
- A change known to break the gene. People also call it a fault or a mutation.
- Variant of uncertain significance
- A change the laboratory cannot yet classify. It should not change your care on its own.
- Moderate-penetrance gene
- A gene whose faults raise risk clearly, but less than the highest-risk genes such as BRCA1.
- Triple-negative breast cancer
- A breast cancer that lacks three common receptors. It is the type most often linked with BARD1 faults.
- Heterozygous
- Carrying one faulty copy and one working copy. Almost every BARD1 carrier is in this position.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
How is BARD1 different from BRCA1?
Commonly believed
What do families get wrong about BARD1?
They are separate genes that work as partners. A fault in one is not a fault in the other, and the risks and advice differ.
For most carriers, closer screening is the usual plan. Surgery is rarely the first suggestion for a moderate-risk gene, though a strong family history can change the discussion.
Men carry and pass on BARD1 faults just as often as women. A father can pass it to his daughter without ever being ill.
It is not. Studies so far are smaller than for BRCA1 and BRCA2, and advice may shift as more families are followed over time.
Being straight with you
What this page cannot tell you
It cannot tell you what your own BARD1 result means. The exact variant, how the laboratory classified it and your family history all change the answer. What your specific variant means is a question for the counsellor who ordered the test.
It cannot give you a personal risk number
Published risk figures for BARD1 come from studies that were mostly done outside India. A genetic counsellor can combine the gene result with your family tree to give a more personal estimate.
Who this does not apply to
Most people do not need a BARD1 test. If nobody in your family has had breast cancer at a young age, and no relative has tested positive, this gene is unlikely to be relevant to you. Tumour testing to guide treatment is a different test, covered under targeted therapy.
Questions we are asked
Common questions about the BARD1 gene
How did BARD1 end up on my report?
Most laboratories now test a panel of many breast cancer genes at once, and BARD1 is often included. It usually appears because it was on the panel, not because a doctor suspected it. That is normal and does not make the finding any less real.
Is a BARD1 fault as serious as a BRCA1 fault?
No. BARD1 is treated as a moderate-risk gene. It raises breast cancer risk clearly, but less steeply than BRCA1. That is why the usual advice is closer screening rather than preventive surgery. Your counsellor will explain where your family sits.
Does BARD1 raise ovarian cancer risk?
So far, studies have not shown a clear rise in ovarian cancer risk. The evidence is still limited, so this could change. If ovarian cancer runs in your family, mention it, because the family history matters as much as the gene.
Can men carry a BARD1 fault?
Yes. Men inherit BARD1 faults exactly as often as women, and each child of a carrier has an even chance of inheriting it. Any extra risk to men themselves has not been clearly shown, but they matter greatly for the rest of the family.
Is BARD1 linked to one type of breast cancer?
Studies link BARD1 faults most strongly with triple-negative breast cancer. This type lacks three common receptors and tends to appear at a younger age. Carriers can still develop other types of breast cancer.
Can the fault be repaired or removed?
No. The fault is in every cell from birth and cannot be corrected. What can change is how closely you are watched, so that any cancer is found early, when treatment is simplest and works best.
My result says BARD1 variant of uncertain significance. What now?
It means the laboratory found a change it cannot yet classify. It is not a positive result, and on its own it should not change your screening. Your care follows your family history. Ask how you will be told if it is ever reclassified.
Where can I get this explained in Telugu?
Genetic counselling at CION can be done in Telugu, and a family member is welcome to join. Bring the report and a list of who in the family had cancer and at what age. Call the helpline and we will arrange the appointment.
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Genetics of Breast and Gynecologic Cancers (PDQ) - Health Professional Version
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
- Cancer Research UK — Inherited cancer genes and increased cancer risk
- NCCN — Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Holding a report that mentions BARD1?
A genetic counsellor can explain what your result means for you and your family, in Telugu if you prefer. One helpline serves every CION centre.